Zai Lab (ZLAB) Shares Outstanding (Weighted Average) (2020 - 2026)
Zai Lab's (ZLAB) quarterly Shares Outstanding (Weighted Average) came in at $1.1 billion in Q1 2026, up 1.1% quarter-over-quarter from $1.1 billion in Q4 2025.
Zai Lab (ZLAB) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends
Zai Lab has disclosed Shares Outstanding (Weighted Average) across 6 years of filings, most recently posting $1.1 billion for Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $1.1 billion, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (changed N/A YoY), and the FY2025 annual result was $1.1 billion, changed N/A from the prior year.
- Shares Outstanding (Weighted Average) came in at $1.1 billion for Q1 2026 at Zai Lab, up from $1.1 billion in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.1 billion in Q1 2026 to a low of $955.5 million in Q1 2022.
- The 4-year median for Shares Outstanding (Weighted Average) is $966.4 million (2023), against an average of $1.0 billion.
- Across the five-year window, Shares Outstanding (Weighted Average) increased 8.12% in 2022 and advanced 0.57% in 2023, its largest moves.
- Zai Lab's Shares Outstanding (Weighted Average) stood at $959.1 million in 2022, then grew by 0.76% to $966.4 million in 2023, then gained by 13.34% to $1.1 billion in 2025, then advanced by 1.1% to $1.1 billion in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 185,491.37 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 400.00 Bn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 100.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 417.01 Bn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 118.76 Bn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 68.88 Bn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 254.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 928.40 Mn |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | 1.11 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.11 Bn |
| Dec 31, 2025 | 1.10 Bn |
| Sep 30, 2025 | 1.10 Bn |
| Jun 30, 2025 | 1.09 Bn |
| Dec 31, 2023 | 966.39 Mn |
| Sep 30, 2023 | 968.77 Mn |
| Jun 30, 2023 | 963.14 Mn |
| Mar 31, 2023 | 961.44 Mn |
| Sep 30, 2022 | 959.09 Mn |
| Jun 30, 2022 | 957.68 Mn |
| Mar 31, 2022 | 955.50 Mn |
| Sep 30, 2021 | 921.75 Mn |
| Jun 30, 2021 | 907.23 Mn |
| Mar 31, 2021 | 883.75 Mn |
| Sep 30, 2020 | 74.38 Mn |
| Jun 30, 2020 | 73.85 Mn |
| Mar 31, 2020 | 72.96 Mn |